China, Sept. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Prospective Clinical Trial of Preliminary Efficacy and Safety of the Combination of 177Lu-FAP-2286 and 177Lu-DOTATATE (Cocktail Therapy) for Advanced Grade 3 Gastroenteropancreatic Neuroendocrine Tumors (FAP-TATE Trial)'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600132243
Registration Time: 2026/09/11
Type: Interventional study
Primary Sponsor: The affiliated hospital of southwest medical university
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=342868
Published by HT Digital Content Services with permission from Health Daily Digest....